Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.
Saved in:
| Title: | Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice. |
|---|---|
| Authors: | Duyvestyn JM; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Taylor SJ; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Dagger SA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Orandle M; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America., Morse HC 3rd; Virology and Cellular Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America., Thien CB; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia., Langdon WY; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia. |
| Source: | PloS one [PLoS One] 2014 Apr 09; Vol. 9 (4), pp. e94717. Date of Electronic Publication: 2014 Apr 09 (Print Publication: 2014). |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
